Company News

In recent years, a series of documents such as the 13th Five Year Plan for the Development of Traditional Chinese Medicine and the White Paper on Traditional Chinese Medicine in China have created a favorable external environment for the development of the traditional Chinese medicine industry; The Chinese Medicine Law of the People's Republic of China provides a legal basis for the traditional Chinese medicine industry.

Hongjitang Pharmaceutical has established good relations with the Korea Pharmaceutical Trade Association, and the focus of cooperation between the two sides includes drug trade, technical exchanges, and market promotion in multiple fields. Hongjitang stated that this cooperation will provide strong support for the company's internationalization strategy, while also bringing more international cooperation opportunities and development space for the company. Through this cooperation, Hongjitang will further expand its influence in the international market and make positive contributions to promoting traditional Chinese medicine to the world and promoting cooperation in drug trade between China and South Korea.

On the morning of September 3rd, the kickoff meeting of Hongjitang Pharmaceutical LIMS (Laboratory Information Management System) project was successfully held in a warm atmosphere. Yan Rui, Vice President of Sinovate Technology Co., Ltd., Wu Youmao, Project Director, Zhang Ran, President of Hongjitang Pharmaceutical, Liu Xingcun, Vice President, Liu Cejia, and other senior leaders and core members of the project attended the project launch meeting, marking the substantive stage of cooperation between the two parties.

Hongjitang, a leading pharmaceutical company, recently participated in the CPHI exhibition and achieved complete success. The event provided an excellent platform for the company to showcase its innovative products and cutting-edge technologies. During the exhibition, Hongjitang reached a strategic cooperation agreement with Agathonbio, a renowned biotechnology company. This collaboration has opened up new opportunities for the development of both parties and is set to have a significant impact on the pharmaceutical and biotechnology industries.

In 1983, the Health Department of Shandong Province instructed the Jinan Traditional Chinese Medicine Factory (now Hongjitang Pharmaceutical) to develop a medicine for treating and protecting the throat. Jinming tablets started research and development in 1987, and devoted themselves to it. Finally, they were successfully developed in June 1990 and obtained the national new drug certificate and approval number in 1991. They were put into the market in 1992. Subsequently, in May 1994, Jinming tablets won the first prize of Jinan Science and Technology Progress Award

On August 23, 2024, the 8th China Time honored Brands (Shandong) Expo was grandly opened at the Shandong International Convention and Exhibition Center. More than 600 enterprises from 26 provinces and cities across the country gathered together, and as one of the first batch of Chinese time-honored brand enterprises, Smart National Pharmaceutical Hongjitang was also invited to participate in the exhibition.

Recently, the Department of Industry and Information Technology of Shandong Province announced the list of suppliers for intelligent factories, digital workshops, intelligent manufacturing scenarios, and system solutions at the provincial level in 2024. Hongjitang Pharmaceutical (Laiwu) Intelligent Factory, with its advanced intelligent manufacturing technology, was successfully selected for the list of provincial intelligent factories in 2024 and honored to be on the list, becoming a model of intelligent transformation in the traditional Chinese medicine pharmaceutical industry in Shandong Province!

Hongjitang will participate in the CPHI exhibition in South Korea on August 27th. This prestigious event provides us with an excellent platform to showcase our latest products and innovations in the pharmaceutical industry.

Faced with the raging influenza virus, the highly recommended compound Xiling Detoxification Capsules protect your health! Compound Xiling Jiedu Capsule is recommended by the influenza Diagnosis and Treatment Plan of Traditional Chinese Medicine in Shandong Province (2022 Edition). It was included in the diagnosis and treatment plan of COVID-19 prevention and treatment by the National Health Commission and the Shandong Health Commission, and was included in the "Class B, Administration B" and "Drug Catalog of COVID-19 Infected Persons" in Shandong Province.

On August 14th, the 17th Health Industry (International) Ecological Conference 2024 Xipu Conference came to a successful conclusion. At this grand event, Hongjitang Pharmaceutical showcased the new pulse and vigorous vitality of smart Chinese medicine to the field of health with outstanding performance. Its brilliant achievements in high-quality development have won high recognition and widespread praise from industry associations, and won multiple industry awards in one fell swoop. Hongjitang Pharmaceutical not only continues to lead the new direction of smart Chinese medicine, but also injects strong momentum into the steady progress of the entire industry!